SEK 84.45
Key Takeaways
Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, overpr
Target Price
The average target price of SUS.ST is 171 and suggests 102% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
